Abstract
A, b, c) Tumor bearing mice received three injections of either 2 µg XE-mTNF or 2 µg KSF-mTNF(a), 30 µg XE-hIL2 or 30 µg KSF-hIL2(b) or 80 µg XE-mIFNa2 or 80 µg KSF-mIFNa2(c)or saline (PBS) as control, starting when tumors reached a size of 90 mm3. Data are represented as mean (n=3) + SEM. Statistical significance is shown on day 15, n.s.=non-significant, *p<0.05, ***p<0.0005, ****p<0.0001. d, e, f) Body weight change during the treatment phase of the therapies depicted in a, b, c. g) Pictures of representative tumor growth taken before (day 7) and after treatment (day 12).